The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progression

Breast Cancer Research and Treatment

Volumn 36, Issue 2, 1995, Pages 119-126

  Volpert, Olga V ^a   Stellmach, Veronica ^a   Bouck, Noel ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

breast carcinoma cell lines; neovascularization; p53; thrombospondin; tumor suppressor genes

Indexed keywords

PROTEIN P53; THROMBOSPONDIN;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; BREAST CARCINOMA; CARCINOMA CELL; ENDOTHELIUM CELL; GENE CONTROL; GENE REPRESSION; HUMAN; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; TUMOR VASCULARIZATION;

ANIMAL; BREAST NEOPLASMS; CELL ADHESION MOLECULES; DISEASE PROGRESSION; DOWN-REGULATION; HUMAN; MEMBRANE GLYCOPROTEINS; NEOVASCULARIZATION, PATHOLOGIC; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; THROMBOSPONDINS;

EID: 0029128416     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/BF00666034     Document Type: Article

References (56)

1. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1
2. The p53 tumor suppressor gene inhibits angiogenesis by stimulating the production of thrombospondin
3. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
4. Inhibition of angiogenesis by vitamin D3 analogues
5. Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3
6. 1,25-dihydroxyvitamin D3 enhances the growth of tumors in thymic mice inoculated with receptor rich osteosarcoma cells
7. Inhibition of angiogenesis by interferons: Effects on tumor- and lymphocyte-induced vascular responses
8. Inhibition of cell motility by interferon
9. Interferons in therapy of solid tumors
10. Kaposi's sarcoma and the acquired immunodeficiency syndrome: treatment with high and low doses of recombinant leukocyte A interferon
11. Interaction of interleukin-1 and interferon-γ on fibroblast growth factor-induced angiogenesis
12. Inhibition of endothelial cell proliferation by gamma-interferon
13. Inhibition of in vitro angiogenesis by lymphotoxin and interferon-γ
14. Differential effects of interferon gamma and alpha on in vitro model of angiogenesis
15. Interleukin 1 is an autocrine regulator of human endothelial cell growth
16. Antitumor effect of recombinant human interleukin 1 alpha against murine syngeneic tumors
17. Effect of interleukin-1-beta on metastasis formation in different tumor systems
18. The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth
19. 2-methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the cholchicine site
20. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides
21. Growth inhibition of murine melanoma and human colon carcinoma by recombinant human platelet factor-4
22. Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity
23. Stimulation and inhibition of angiogenesis by the placental proliferin and proliferin-related protein
24. The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis
25. Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activities of angiogenin
26. A ribonuclease inhibitor expresses anti-angiogenic properties and leads to reduced tumor growth in mice
27. Protamine is an inhibitor of angiogenesis
28. Protamine sulfate inhibits mitogenic activities of the extracellular matrix and fibroblast growth factor, but potentiates that of epidermal growth factor
29. Inhibition of angiogenesis through modulation of collagen metabolism
30. A highly potent antiangiogenic activity of retinoids
31. Retinoic acid is an effective antiangiogenic agent in IL-8 producing oral squamous cell carcinomas [abstract]
32. Retinoids in cancer prevention and therapy
33. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene
34. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin
35. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity
36. Specific inhibition of endothelial cell proliferation by thrombospondin
37. Platelet thrombospondin modulates endothelial cell adhesion, motility and growth: a potential angiogenesis regulatory factor
38. Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro
39. Antiangiogenic activity of thrombospondin-1 and its peptides [abstract]
40. Downregulation of endothelial cell thrombospondin 1 enhances in vitro angiogenesis
41. Tsp-1 and its peptides block angiogenesis by making endothelial cells refractory to stimuli and by enhancing differentiation [abstract]
42. Identification of an inhibitor of neovascularization from cartilage
43. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation
44. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase
45. Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of metalloproteinases-1
46. Abnormal oxidative metabolism of estradiol in women with breast cancer
47. Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking
48. Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells
49. Chromosome 10 regulates the angiogenic phenotype in glioblastoma cells by modulating thrombospondin [abstract]
50. Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast
51. Thrombospondin and other possible related matrix proteins in malignant and benign breast disease
52. Localization of thrombospondin and its cysteine-serine-valine-threonine-cysteine-glycine-specific receptor in human breast carcinoma
53. Suppression of tumor-forming ability and related traits in MCF-7 human breast cancer cells by fusion with immortal mammary epithelial cells
54. Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential and angiogenesis
55. Tumor suppressor genes and their roles in breast cancer
56. Tumor suppressor activity of RB and p53 genes in human breast carcinoma cells